Your Position: Home
> Asthma Therapeutic Targets Asthma Therapeutic Targets
| Protein Name | Alternative Names | BioChemical Class / Role | Products (Cat NO)![]() |
||
| Protein | Antibody | Gene cDNA clones | |||
| ADRB2 | HG10378-M | ||||
| ELA2 | MG50204-M | ||||
| Integrin alpha 4/CD49d | ITGA4.IA4, MGC90518 | CD49d is an integrin alpha subunit. It makes up half of the α4β1 lymphocyte homing receptor. Integrins alpha-4/beta-1 (VLA-4) and alpha-4/beta-7 are receptors for fibronectin. On activated endothelial cells integrin VLA-4 triggers homotypic aggregation for most VLA-4-positive leukocyte cell lines. It may also participate in cytolytic T-cell interactions with target cells. | MG50049-M | ||
| PARP-1/PARP | PARP1, ADPRT, ADPRT1, RP11-125A15.2, PPOL, pADPRT-1 | Poly (ADP-ribose) polymerase 1(PRAP1), also known as NAD(+) ADP-ribosyltransferase 1(ADPRT), is a chromatin-associated enzyme which modifies various nuclear proteins by poly(ADP-ribosyl)ation. PARP1 is critical for a wide range of processes, including DNA repair, regulation of chromosome structure, transcriptional regulation, mitosis and apoptosis. It is involved in differentiation, proliferation, and tumor transformation. Additionally, it may participate in the pathophysiology of type I diabetes. | 11040-H08B | HG11040-M | |
| TNF-alpha | TNF, TNFA, TNFSF2, DADB-70P7.1, DIF | TNF-alpha (Tumor necrosis factor alpha ), also known as TNF, TNFA or TNFSF2, is the prototypic cytokine of the TNF superfamily, and is a multifunctional molecule involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. TNF-alpha is involved in fighting against the tumorigenesis, thus, is regarded as a molecular insight in cancer treatment. | 10602-HNA 50349-MNAE |
10602-MM01 10602-MM02, 10602-RP03 |
HG10602-M MG50349-M |
| CXCR2/ CD182/ CD128b/IL-8RB |
HG10788-M | ||||
| E-Selectin/CD62e | ELAM-1, ELAM1, ELAM, SELE, RP1-117P20.2, ESEL, LECAM2 | E-selectin, also known as endothelial leukocyte adhesion molecule-1 (ELAM-1) and CD62e, is an inducible adhesion molecule. E-selectin supports rolling and stable arrest of leukocytes on activated vascular endothelium, and furthermore, it was indicated that it can also transduce an activating stimulus via the MAPK cascade into the endothelial cell during leukocyte adhesion. In addition, this adhesion molecule appears to be involved in the pathogenesis of atherosclerosis. | 10335-H03H, 10335-H08H | HG10335-M | |
| ICAM-1/CD54 | ICAM1, BB2, CD54, P3.58 | ICAM-1 (Inter-Cellular Adhesion Molecule 1), also known as CD54, is a type of intercellular adhesion molecule constitutely present in low concentrations in the membranes of leukocytes and endothelial cells. ICAM-1 is well known for its importance in stabilizing cell-cell interactions and facilitating leukocyte endothelial transmigration. It also becomes known for its affinity for Plasmodium falciparum-infected erythrocytes (PFIE), providing more of a role in infectious disease. | 10346-H03H 10346-H08H 10346-HCCH |
HG10346-M | |
| IL-13 | ALRH, BHR1, IL13, MGC116786, MGC116788, MGC116789, P600 | IL-13, a single-chain glycosylated polypeptide, is critical in regulating inflammatory and immune responses. IL-13 is associated primarily with the pathophysiology of atopic respiratory diseases such as allergic asthma. In addition, studies have identified IL13 expression as a common feature of cHL (classical Hodgkin lymphoma). | 10369-H01H 11057-CNAH |
10369-MM01 10369-MM02 |
HG10369-M MG50225-M 11057-M |
| IL-4R/CD124 | IL4RA | IL-4R is a type I transmembrane protein that can bind interleukin 4 and interleukin 13 to regulate IgE antibody production in B cells. Soluble IL4R (sIL4R) inhibits IL4-mediated cell proliferation and IL5 up-regulation by T-cells. Allelic variations in this gene have been associated with atopy, a condition that can manifest itself as allergic rhinitis, sinusitus, asthma, or eczema. | 10402-H08H | 10402-RP01 | HG10402-M |
| Syk | HG10540-M | ||||
+86-400-890-9989




